Europa · Agencias y tiempo real · Reuters Business

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand

Publicado por Reuters Business · Reino Unido hace 9 h

Indian drugmaker Torrent Pharmaceuticals reported a near 10% decline in second-quarter profit on Friday, as higher spending on ‌research and development outpaced robust demand…

Leer el artículo completo en Reuters Business Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.reuters.com)

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand

También te puede interesar

Tsunami warning issued for Sicily following tremors — newspaper

Türkiye urges stronger financing partnerships to turn COP31 pledges into investment

First Russian diesel from Putin-Trump deal heading for US, data shows

Ready for a French test?: Five questions for the ECB

South32 aprova venda à Alcoa e deixa fundição moçambicana Mozal de fora

Global equity funds attract inflows for a fifth consecutive week

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand

Compartir

También te puede interesar

Tsunami warning issued for Sicily following tremors — newspaper

Türkiye urges stronger financing partnerships to turn COP31 pledges into investment

First Russian diesel from Putin-Trump deal heading for US, data shows

Ready for a French test?: Five questions for the ECB

South32 aprova venda à Alcoa e deixa fundição moçambicana Mozal de fora

Global equity funds attract inflows for a fifth consecutive week